Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Effects of Oral Administration of N-Acetyl-l-cysteine

A Multi-Biomarker Study in Smokers

Frederik Jan Van Schooten, Ahmad Besarati Nia, Silvio De Flora, Francesco D’Agostini, Alberto Izzotti, Anna Camoirano, Alfons J. M. Balm, Jan Willem Dallinga, Aalt Bast, Guido R. M. M. Haenen, Laura Van’t Veer, Paul Baas, Harumasa Sakai and Nico Van Zandwijk
Frederik Jan Van Schooten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmad Besarati Nia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvio De Flora
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco D’Agostini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Izzotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Camoirano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfons J. M. Balm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Willem Dallinga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aalt Bast
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido R. M. M. Haenen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Van’t Veer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Baas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harumasa Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nico Van Zandwijk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published February 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Correction for vol 11, p 167 - July 19, 2005

Abstract

N-Acetyl-l-cysteine (NAC) has been shown to exert cancer-protective mechanisms and effects in experimental models. We report here the results of a randomized, double-blind, placebo-controlled, Phase II chemoprevention trial with NAC in healthy smoking volunteers. The subjects were supplemented daily with 2 × 600 mg of oral tablets of NAC (n = 20) or placebo (n = 21) for a period of 6 months, and internal dose markers [plasma and bronchoalveolar lavage (BAL) fluid cotinine, urine mutagenicity], biologically effective dose markers [smoking-related DNA adducts and hemoglobin (Hb) adducts], and biological response markers (micronuclei frequency and antioxidants scavenging capacity) were assessed at both pre- and postsupplementation times (T0 and T1, respectively). Overall, the internal dose markers remained unchanged at T1 as compared with T0 in both NAC and placebo groups. When quantifying the biologically effective dose markers, we observed an inhibitory effect of NAC toward the formation of lipophilic-DNA adducts (5.18 ± 0.73 versus 4.08 ± 1.03/108 nucleotides; mean ± SE; P = 0.05) as well as of 7,8-dihydro-8-oxo-2′-deoxyguanosine adducts in BAL cells (3.9 ± 0.6 versus 2.3 ± 0.2/105 nucleotides; P = 0.003). There was no effect of NAC on the formation of lipophilic-DNA adducts in peripheral blood lymphocytes or polycyclic aromatic hydrocarbon-DNA adducts in mouth floor/buccal mucosa cells or 4-aminobiphenyl-Hb adducts. Likewise, quantification of the biological response markers showed an inhibitory effect of NAC on the frequency of micronuclei in mouth floor and in soft palate cells (1.3 ± 0.2 versus 0.9 ± 0.2; P = 0.001) and a stimulating effect of NAC on plasma antioxidant scavenging capacity (393 ± 14 versus 473 ± 19 μm Trolox; P = 0.1) but not on BAL fluid antioxidant scavenging capacity. We conclude that NAC has the potential to impact upon tobacco smoke carcinogenicity in humans because it can modulate certain cancer-associated biomarkers in specific organs.

  • Received March 12, 2001.
  • Revision received November 14, 2001.
  • Accepted November 20, 2001.
View Full Text
PreviousNext
Back to top
February 2002
Volume 11, Issue 2
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Oral Administration of N-Acetyl-l-cysteine
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effects of Oral Administration of N-Acetyl-l-cysteine
Frederik Jan Van Schooten, Ahmad Besarati Nia, Silvio De Flora, Francesco D’Agostini, Alberto Izzotti, Anna Camoirano, Alfons J. M. Balm, Jan Willem Dallinga, Aalt Bast, Guido R. M. M. Haenen, Laura Van’t Veer, Paul Baas, Harumasa Sakai and Nico Van Zandwijk
Cancer Epidemiol Biomarkers Prev February 1 2002 (11) (2) 167-175;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effects of Oral Administration of N-Acetyl-l-cysteine
Frederik Jan Van Schooten, Ahmad Besarati Nia, Silvio De Flora, Francesco D’Agostini, Alberto Izzotti, Anna Camoirano, Alfons J. M. Balm, Jan Willem Dallinga, Aalt Bast, Guido R. M. M. Haenen, Laura Van’t Veer, Paul Baas, Harumasa Sakai and Nico Van Zandwijk
Cancer Epidemiol Biomarkers Prev February 1 2002 (11) (2) 167-175;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Gallstones and Gallbladder Cancer
  • Additive Effects of Aristolochic Acid and Arsenic in UTUC
  • Provider Lifestyle Discussions
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement